Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Effective Interest Rate on Debt % : 15.05% (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Cannabis Bioscience International Holdings's annualized positive value of Interest Expense for the quarter that ended in Nov. 2023 was $0.08 Mil. Cannabis Bioscience International Holdings's average total debt for the quarter that ended in Nov. 2023 was $0.51 Mil. Therefore, Cannabis Bioscience International Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Nov. 2023 was 15.05%.

Cannabis Bioscience International Holdings Effective Interest Rate on Debt % Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Effective Interest Rate on Debt % Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

Effective Interest Rate on Debt %

14.29

3.01

7.99

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial							4.50	14.18	0.59	2.66	15.05

Competitive Comparison of Cannabis Bioscience International Holdings's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Effective Interest Rate on Debt % falls into.

Cannabis Bioscience International Holdings Effective Interest Rate on Debt % Calculation

Cannabis Bioscience International Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in May. 2011 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: May. 2010 )	+	Total Debt (A: May. 2011 ))	/ count )
=	-1 * -0.365	/	( (5.453	+	3.687)	/ 2 )
=	-1 * -0.365	/	4.57
=	7.99 %

where

	Total Debt (A: May. 2010 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.186	+	3.267
=	5.453

	Total Debt (A: May. 2011 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.516	+	3.171
=	3.687

Cannabis Bioscience International Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Nov. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Nov. 2022 )	+	Total Debt (Q: Nov. 2023 ))	/ count )
=	-1 * -0.076	/	( (0	+	0.505)	/ 1 )
=	-1 * -0.076	/	0.505
=	15.05 %

where

	Total Debt (Q: Nov. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (Q: Nov. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.283	+	0.222
=	0.505

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Nov. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Cannabis Bioscience International Holdings (OTCPK:CBIH) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Cannabis Bioscience International Holdings Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.